The vision of the CardioPulmonary Vascular Biology Center of Biomedical Research Excellence (CPVB COBRE) is to advance understanding of vascular diseases affecting the pulmonary and cardiovascular systems. This vision will be accomplished through research performed by a multidisciplinary group of outstanding investigators who are using cutting edge tools to understand the pathobiology of vascular diseases. In this phase II application we seek to renew funding for a second 5 years. We will continue the research partnership of three collaborating institutions?Ocean State Research Institute (OSRI), the Rhode Island Hospital, and Brown University. The applicant institution, OSRI, is the research and education nonprofit associated with the Providence VA Medical Center, a teaching hospital affiliated with the Warren Alpert Medical School of Brown University. In Phase I, the CPVB COBRE supported development of a community of researchers, provided career development and research skill training, and stimulated new research collaborations among the investigators, mentors, and other faculty. Strong institutional support brought expert visitors to the center, resulting in additional research collaborations. Teaching and mentoring activities of CPVB COBRE investigators enhanced knowledge of vascular biology among undergraduate and graduate students, as well as postdoctoral trainees and junior faculty. CPVB COBRE investigators have competed successfully for $7.61 million in research funding during Phase I. Similar approaches will be used during Phase II, and five outstanding junior investigators have been identified who bring complementary backgrounds, skills, and research interests. New areas of research will be pursued using innovative approaches that expand the scope of COBRE technical resources. Thus, the CPVB COBRE will continue to broaden the scope and depth of vascular biology research at the partnering Rhode Island institutions. The CardioPulmonary Vascular Biology COBRE proposes the following specific aims for Phase II of funding: (1) Create a multidisciplinary group of investigators in studies of vascular injury and repair. (2) Provide research support, protected time, and mentoring to enable junior investigators to become independent scientists and provide robust support for research career and professional development. (3) Expand the CardioPulmonary Vascular Biology Center into new research areas and thereby enhance and broaden vascular biology research at collaborating institutions. (4) Provide services supporting vascular biology research and develop a self-sustaining Cell/Organ Core. Accomplishment of these aims will result in a strengthened and broadened CardioPulmonary Vascular Biology COBRE that will be the basis for new interdisciplinary scientific collaborations, significant contributions to understanding of pulmonary and cardiovascular diseases, and improvements in the health of the citizens of Rhode Island and the nation.

Public Health Relevance

The vision of the CardioPulmonary Vascular Biology Center of Biomedical Research Excellence (CPVB COBRE) is to advance understanding of diseases of the blood vessels. This vision will be accomplished through research of a group of outstanding investigators who are using cutting edge tools to understand diseases of the blood vessels. The CardioPulmonary Vascular Biology COBRE will be strengthened and broadened and will provide the basis for new scientific collaborations, important contributions to understanding of blood vessel diseases, and improvements in the health of the citizens of Rhode Island and the nation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM103652-08
Application #
9979877
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Davani, Behrous
Project Start
2013-09-20
Project End
2023-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
8
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Ocean State Research Institute, Inc.
Department
Type
DUNS #
848476271
City
Providence
State
RI
Country
United States
Zip Code
02908
Baird, Grayson L; Archer-Chicko, Christine; Barr, R Graham et al. (2018) Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension. Eur Respir J 51:
Shah, Nishant R; Blankstein, Ron; Villines, Todd et al. (2018) Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy. Curr Cardiovasc Imaging Rep 11:26
Monaghan, Sean F; Banerjee, Debasree; Chung, Chun-Shiang et al. (2018) Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness. Mol Med 24:32
Potz, Brittany A; Scrimgeour, Laura A; Pavlov, Vasile I et al. (2018) Extracellular Vesicle Injection Improves Myocardial Function and Increases Angiogenesis in a Swine Model of Chronic Ischemia. J Am Heart Assoc 7:
Zhou, Yang; He, Chuan Hua; Yang, Daniel S et al. (2018) Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky-Pudlak Syndrome Lung Disease. J Immunol 200:2140-2153
Zhao, Haifeng; Dennery, Phyllis A; Yao, Hongwei (2018) Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 314:L544-L554
Chambers, Eboni; Rounds, Sharon; Lu, Qing (2018) Pulmonary Endothelial Cell Apoptosis in Emphysema and Acute Lung Injury. Adv Anat Embryol Cell Biol 228:63-86
Sellke, Nicholas; Kuczmarski, Alex; Lawandy, Isabella et al. (2018) Enhanced coronary arteriolar contraction to vasopressin in patients with diabetes after cardiac surgery. J Thorac Cardiovasc Surg 156:2098-2107
Fallon, Eleanor A; Biron-Girard, Bethany M; Chung, Chun-Shiang et al. (2018) A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis. J Leukoc Biol :
Aldosari, Sarah; Awad, Maan; Harrington, Elizabeth O et al. (2018) Subcellular Reactive Oxygen Species (ROS) in Cardiovascular Pathophysiology. Antioxidants (Basel) 7:

Showing the most recent 10 out of 96 publications